Human Papillomavirus Vaccination Is Not Exclusively a Matter of Price

Author： Capone Alessandro   Favato Giampiero  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.30, Iss.5, 2012-05, pp. : 443-444

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A cost-effectiveness analysis of human papillomavirus vaccination of boys for the prevention of oropharyngeal cancer

By Graham Donna M.   Isaranuwatchai Wanrudee   Habbous Steven   de Oliveira Claire   Liu Geoffrey   Siu Lillian L.   Hoch Jeffrey S.  

Cancer, Vol. 121, Iss. 11, 2015-06 ,pp. : 1785-1792

Blackwell Publishing

Access to resources Recommend Favorite

Trends in cervical intraepithelial neoplasia Grade 2+ after human papillomavirus vaccination: The devil is in the details

By  

Cancer, Vol. 121, Iss. 16, 2015-08 ,pp. : 2674-2677

Blackwell Publishing

Access to resources Recommend Favorite

Are we missing an opportunity for cancer prevention? Human papillomavirus vaccination for survivors of pediatric and young adult cancers

By  

Cancer, Vol. 121, Iss. 19, 2015-10 ,pp. : 3395-3402

Blackwell Publishing

Access to resources Recommend Favorite

Emerging human papillomavirus vaccines

By Christensen Neil D  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 1, 2005-02 ,pp. : 5-19

Informa Healthcare

Access to resources Recommend Favorite

Emerging human papillomavirus vaccines

By Ma Barbara  

Expert Opinion on Emerging Drugs, Vol. 17, Iss. 4, 2012-12 ,pp. : 469-492

Informa Healthcare

Access to resources Recommend Favorite